- Siemens Healthineers Brasil
- Diagnóstico laboratorial
- Ensaios por doenças e condições
- Diabetes
- Diagnostic testing for diabetes and diabetes-related conditions
Tests for Diabetes and Its Related ConditionsWhy choose Siemens Healthineers?
Important diabetes tests
Tests that everyone with diabetes should receive
- Hemoglobin A1c blood glucose test (recommended every 3–6 months)1
- Lipid panel test for total cholesterol, HDL, LDL, and triglycerides (recommended once per year)1
- Urine test to check kidney health (recommended once per year)1
- Blood test to check heart health (recommended once per year)2
- Liver function test (recommended once per year)1
Why get these tests?
Why should everyone with diabetes receive these tests?
Diabetes seldom occurs in isolation. A diabetes diagnosis is often accompanied by related conditions such as cardiovascular disease, kidney problems, foot and lower limb complications, nonalcoholic fatty liver disease (NAFLD), and hyperglycemia in pregnancy.
With 45% of people with diabetes undiagnosed,3 or diabetes recognized only when life-threatening complications develop, testing is critical to diagnose and provide appropriate and timely care.
Diabetes and its related conditions
Why choose Siemens Healthineers?
Assay menu
The broad and expanding Atellica® Solution menu includes high-performing routine, esoteric, lipid, cardiac, kidney, and liver-related assays, making test consolidation on a single, automated platform easy and effective.
| ||||||
Routine and Esoteric Diabetes Assays | ||||||
C-Peptide | √ |
| √ |
|
| √ |
Fructosamine |
| √ | √ | √*§ | √*§ |
|
Glucose |
| √† | √ | √ | √ |
|
HbA1c |
| √ | √ | √** | √** |
|
Insulin | √ |
| √ |
|
| √ |
Chemistry (Lipid) Assays | ||||||
Cholesterol | √† | √ | √ | √ | ||
HDL Cholesterol | √ | √ | √ | √ | ||
LDL Cholesterol | √ | √ | √ | √ | ||
Triglycerides | √† | √ | √ | √ | ||
Cardiac Assays | ||||||
BNP | √ | √ | √‡ | √§ | ||
CKMB Mass | √ | √ | √ | √ | √§ | |
CKMB Isoenzyme | √ | √ | ||||
D-Dimer | ä | |||||
High-Sensitivity CRP | √ | √ | √ | √ | √ | |
High-Sensitivity Troponin I | √ | √ | √ | √ | ||
Myoglobin | √ | √ | √ | √ | √ | |
NT-proBNP | √§ | √§ | √ | √ | √§ | |
Troponin I | √ | |||||
Kidney Assays | ||||||
β2 Microglobulin | √ | √ | √*§ | √ | √ | |
Creatinine | √† | √ | √ | √ | ||
Creatinine, Enzymatic | √ | √ | √ | √ | ||
Cystatin C | √ | √ | √ | |||
Urinary Albumin/Microalbumin | √ | √ | √ | √ | ||
Urea Nitrogen |
| √† | √ | √ | √ | |
Liver Assays | ||||||
Enhanced Liver Fibrosis (ELF™) Test | √ | √ |
Webinar: Diabetes—beyond HbA1c
Join Dr. Youssef Maakaroun, MD, as he discusses the various conditions associated with diabetes and how innovative assays can help optimize management of diabetes patients and route them for proper care.
Importance of hemoglobin A1c testing for diabetes diagnosis and management post-COVID-19 infection (2023)
MLO: Early identification and treatment of the disease can improve health outcomes by avoiding or delaying long-term diabetic complications.
NAFLD/NASH prevalence in type 2 diabetes patients and use of noninvasive tests
Looking for point-of-care (POC) diabetes testing solutions? Get information on Siemens Healthineers POC diabetes testing solutions.